• Search
  • Helpdesk
  • Sales contact
Get your demo

Céline Hollinger

Celine brings almost two decades of communications experience in the life sciences. As a co-founder of a healthcare communication agency for over a decade, she has supported top pharma and innovative healthcare companies. Since April 2019, she has been leading marketing and communication at Kayentis with her innovative strategies.

Kayentis and RWS join forces to improve data confidence in neuroscience clinical trials

Interoperability
Combining best-in-class electronic Clinical Outcome Assessment (eCOA) technology with expert rater training to reduce variability and strengthen clinical outcomes data in Central Nervous System (CNS) and other complex disorder clinical...

What if eCOA could elevate your next rare disease trial?

Rare disease
 Interview with Prof. Olivier Blin, Professor of Pharmacology, rare disease expert, and Orphan Dev coordinator Despite remarkable progress in rare...

Elevating rare disease clinical trials through eCOA – From patient voice to regulatory success

Rare disease
Rare disease clinical trials face a unique combination of scientific, operational, and regulatory challenges. Small patient populations, heterogeneous disease presentation,...

Overcoming rare disease trial challenges: the strategic impact of eCOA

Rare disease
Rare disease trials are crucial for addressing major unmet medical needs, yet they are among the most challenging to design...

Kayentis and Perceptive eClinical partner to tackle increasing digital system complexity in global clinical trials

Interoperability
Top-tier expertise in electronic Clinical Outcome Assessment (eCOA) and Interactive Response Technology (IRT), combined in seamless integrated solution, will enable...

Raising the bar again: Kayentis achieves 95.9% client Recommendation Rate and +72 NPS

At Kayentis, we are proud to share the results of our latest client survey, conducted in January 2026. This year’s...

PCMG 2026

JUNE 16-17 2026 • Berlin, Germany
Register For PCMG26 Updates - PCMG 2026 Annual Assembly

OCT East Coast 2026

MAY 12-13 2026 • New Brunswick, NJ, USA
Booth #7 17th Annual Outsourcing in Clinical Trials East Coast 2026 - Arena International

OCT Europe 2026

MAY 6-7 2026 • Barcelona, Spain
Booth #59 16th Annual Outsourcing in Clinical Trials Europe 2026 - Arena International

2026 Precision in Clinical Trials

APR 30 - MAY 1 2026 • Boston, MA, USA
Booth #3 Precision In Clinical Trials Summit | April 30 - May 1 - Boston

C-PATH 2026

APR 16-17 2026 • Washington, D.C. USA

Kayentis and Ametris join forces to deliver integrated eCOA solution measuring and improving wearable technology adherence in clinical trials

Interoperability
More than simply unifying wearable and patient-reported data in one app, integrated solution directly tackles major challenge in wearable enabled...

Breaking barriers in pediatric clinical trials: perspectives from two expert clinicians

Pediatric
Interview with Begoña Nafria, Head of the Patient Engagement in Research Department at SJD Research Foundation in Spain, and Vivienne...

Navigating BYOD in Clinical Research: Insights for Clinical Trial Success

BYOD
As the Bring Your Own Device (BYOD) model gains momentum in clinical research, understanding what to consider and how to...

ePRO in early phase oncology trials: A revolution on the horizon

Oncology
While the integration of Patient-Reported Outcomes (PROs) into phase IIb and III clinical trials has become increasingly widespread in the...

Patient-Reported Outcomes in early-phase oncology clinical trials
A Stepping Stone to a Patient-Centered Drug Development

Oncology
In phase I clinical trials, the recommended phase II dose (RP2D) is usually set at or near the maximum tolerated...

Answering the Sustainability Call: Digital Health Technologies and eCOA

CSReCOA consortium
With over 350,000 registered clinical trials worldwide, the research industry contributes an estimated 27.5 million tons of CO₂ equivalent, highlighting...

Kayentis secures Silver Medal in EcoVadis sustainability evaluation with significant score improvement

CSR
Ranked in the top 9% globally in the industry, Kayentis solidifies its position as a leading provider committed to sustainability...

Engage patients throughout the clinical trial journey

Patient engagement
Want to engage patients throughout the clinical trial journey? Boost retention and drive compliance with patient engagement modules seamlessly integrated...

Rethinking Phase 1 Oncology Trials with Electronic Patient-Reported Outcomes

OncologyPRO
The primary aim of Phase 1 oncology clinical trials is to determine the safety of a new treatment, and to...

Kayentis accelerates US growth with 40% surge in bookings over the last year and major Top Pharma wins – Amy Jones appointed Chief Commercial Officer to amplify and sustain expansion

Kayentis deploys a record US expansion in 2025 driven by strategic partnerships; new Chief Commercial Officer (CCO) Amy Jones will...

Empowering patients through education – A structured approach to clinical trial engagement

Patient engagement
In the evolving landscape of clinical research, patient engagement has emerged as a cornerstone of successful clinical trials. In addition...

Kayentis introduces its Patient Education Video Library to strengthen clinical trial engagement and compliance

Patient engagement
Co-created with patient advocates and integrated into the Kayentis electronic Clinical Outcome Assessment (eCOA) application, patient educational videos enrich Kayentis’...

Expanding investor confidence: The strategic value of Patient Reported Outcomes (PROs) in biotech fundraising

biotechfundraisingPRO
For biotech companies engaged in the clinical development of a therapeutic innovation, securing investor trust is as critical as demonstrating...

Leveraging the potential of Patient Reported Outcome (PRO) data to accelerate therapeutic innovation market access

biotechmarket accessPRO
Patients Reported Outcome (PRO) data provide information on patient health that is obtained directly from the patient.PRO measures serve to...

Gastrointestinal Tract Diseases Research: Moving Towards Patient-Centered Clinical Trials

Gastroenterology
The management of gastrointestinal tract diseases, especially inflammatory bowel disease (IBD), has been transformed over the past few decades. This...

The critical importance of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies

biotechPRO
In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....

Turning experience into evidence: PROs in IBD clinical research

Gastroenterology
Inflammatory Bowel Disease (IBD), including Crohn’s disease or Ulcerative Colitis, presents a complex and highly individualized clinical picture, making it...

BYOD on the rise

BYOD
Recent and rapid advances in technology have significantly accelerated the digitalization of clinical trials. The Bring Your Own Device (BYOD)...

Strategies to promote BYOD adoption by clinical study sites

BYOD
Bring Your Own Device (BYOD) approaches have been increasingly adopted in recent years, and the multiple advantages they bring to...

How Kayentis reduces the CO2 emissions of your eCOA projects with its carbon neutral program

CSR
In 2020, we implemented a carbon neutral program for all our clinical trials.Our goal? To reduce project CO2 emissions without...

Empowering patients through data: a collaborative vision of clinical data management

Data management
In the ever-evolving landscape of clinical trials, the importance of patient-centric approaches and effective data management cannot be overstated. This...

If Patients Want A Better Quality Of Life, Why Isn’t That A Focus For Pharma?

OncologyPatient engagement
A conversation with Frédéric Fiteni, Ph.D., medical oncologist and oncology PRO specialist, University Hospital of Nîmes, and, member of Kayentis Scientific...

Strategies to overcome clinical trials complexities

Decentralized trialseCOA
Clinical research has always been complex, but a significant increase in the level of complexity of clinical trials can have...

Data Collection in Clinical Trials with Multiple Caregivers

eCOA consortium
In clinical trials, especially those involving participants unable to self-report—such as children or individuals with cognitive impairments—caregiver-reported data is essential....

Kayentis Achieves a 99% Gender Equality Index in 2025

CSR
In accordance with the provisions of the French "Professional Future" law of September 5, 2018, Kayentis has established its Gender...

Kayentis enlists experts in oncology, neurodegenerative and metabolic disorders to form scientific advisory board

Board’s specialties in rare diseases, oncology, neurosciences, cardiology and metabolic disorders drive Kayentis’ expertise further in aiding pharma and biotech...

Immunology Case Study

Immuno-Inflammation
Immunology studies present specific challenges: their eCOA build can be complex, site staff must play a key role, and study...

The unquestionable value of electronic Clinical Outcome Assessments (eCOA) in rheumatoid arthritis clinical research

Immuno-Inflammation
Rheumatoid Arthritis (RA) is a common, chronic disease that causes inflammation and often presents with pain in the joints. Untreated,...

Ensure successful outcomes with strong patient collaboration at every stage of your clinical trial

Patient engagement
Patients, who live with their conditions daily, have invaluable insights that make them essential partners in developing effective treatments and...

Empowering healing: The impact of patient partnerships in clinical trials

Patient engagement
The landscape of clinical trials has evolved significantly over recent decades, moving from a purely scientific focus to a more...

Collecting PRO data in leukemia clinical research: the only way to meaningfully improve patients’ quality of life

Oncology
The prevalence of leukemia is increasing worldwide. Chronic Myeloid Leukemia (CML) patients benefit from recently improved care but receive prolonged,...

How to improve the collaboration between expert patients and healthcare companies?

Patients insights
Why and how could the partnerships between expert patients and healthcare companies be improved?In this insightful interview, Françoise Sellin, a...

Bringing the patient’s voice to clinical trials

Patient’s voicePatients insights
In this interview, engagement advocate and cystic fibrosis patient Thomas Smith shares his experiences of being the patient voice in...

Collecting PRO data in cancer trials: bringing the patient perspective in oncology clinical research

Oncology
As one of the biggest research area, oncology remains the focus of the clinical trials pipeline, comprising 44% of the...

“Dealing with multiple data sources in clinical trials” webcast

Data management
Dealing with multiple data sources:Fundamental aspects of data integration and reconciliation for high data qualityAs technology's penetration in the clinical...

Improving the clinical trial journey with technology and system integration

Interoperability
Over the last two decades, the clinical trial landscape has rapidly evolved towards more decentralization and increased use of advanced...

Rare disease clinical research: it is time to tackle what matters most to patients

Rare disease
Supporting the development and evaluation of new treatments for rare diseases has become a key priority of the 21st century....

Biotech and eCOA vendor: A shared mindset

Project management
Biotechs play a pivotal role in driving innovation, contributing significantly to the development of groundbreaking therapies for patients. But they...

The client’s voice: why they consistently choose Kayentis

Project management
At Kayentis, client satisfaction isn't just a goal—it's our standard. We pride ourselves on delivering services that embody responsiveness, reliability,...

Why you should join Kayentis

CSR
At Kayentis, we value each individual and we form a community that goes beyond the sum of individuals. Our company’s...

Rethinking pediatric clinical trials: guidelines from pediatric experts

PediatricSites perspectives
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

Overcoming challenges in long-lasting pediatric clinical trials – Insights from site experts

PediatricSites perspectives
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

Tackling the specificities of NASH/MASH clinical trials

Metabolic
Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating chronic illness that significantly impairs...

Mastering pediatric asthma clinical trials

PediatricRespiratory
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of life instruments. Asthma clinical research...

The importance of ePRO to support NASH/NAFLD unmet clinical research and medical needs

MetabolicScientific advice
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally and is the most severe...

How DCTs Can Help Pediatric Clinical Research – Insights From Site Experts

PediatricSites perspectives
In this second episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

Ophthalmology Clinical Trials

Ophthalmology
Ophthalmic conditions and vision impairment currently affect 2.2 billion people globally: Data collection can be very challenging for patients with...

The strengths of electronic Clinical Outcome Assessment (eCOA) versus paper solutions

eCOAScientific advice
In contrast to paper solutions, electronic Clinical Outcome Assessment (eCOA) demonstrates strengths such as:AccuracyCompletenessTimingsAttributabilityUser-friendlinessRegulatory compliance Download the "eCOA vs paper"...

The relevance of ePROs in early phase clinical trials

Scientific advice
Early phase clinical research (phase 1 and 2a) focuses on characterizing the behavior of the investigational product in humans, finding...

3 considerations to take into account when setting up an eCOA clinical trial

Televisit
In a clinical trials environment that is moving increasingly towards digitalization and decentralization, it remains crucial to maintain high-quality electronic...

Kayentis operational excellence

Project management
Why do customers recommend Kayentis for operational excellence? More than 95% of Kayentis customers recommend Kayentis for its:Customer-centric approachEnd-to-end project...

Innovation and Partnerships: The Biotech Perspective

biotechCardiology
In the ever-evolving landscape of biotechnology, groundbreaking advancements continue to shape the future of healthcare. In this exclusive interview, Estelle...

Addressing challenges with eCOA at the site-level

eCOA consortium
The eCOA: Getting Better Together Initiative launched by the Critical Path Institute in 2019 aimed to identify and address issues...

How to avoid common pitfalls when implementing DCT solutions in your clinical trials?

Decentralized trials
In this episode, Ally Hochman, Clinical Operations Project Manager at Kayentis, offers valuable insights into enhancing technology adoption, establishing enduring...

Flexible approaches to eCOA administration in clinical trials: The site perspective

eCOA consortium
To address the need to embed flexibility in eCOA use, the “Support Flexible Approaches to PRO Data Collection” project was...

Decentralized trials: keys to achieving success

Decentralized trials
What extra considerations are required for successfully implementing Decentralized Clinical Trials (DCTs) in addition to those for traditional site-based trials?...

Exploring The Specific Challenges Of Pediatric Clinical Trials – Insights From Site Experts

PediatricSites perspectives
In this first episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

Optimizing caregiver engagement in clinical trials: 4 considerations for high-quality ObsRO data collection

Patient engagement
Caregivers represent a critical yet highly heterogeneous population within clinical trials. Their level of involvement ranges from providing general emotional...

Why you should implement a BYOD strategy for your eCOA trial

BYOD
Improve your clinical trial efficiency and offer more choice to patients by implementing a BYOD strategy for your eCOA trial!...

How Kayentis Helps You Manage The Growing Complexities Of eCOA Trials

Project management
We all know clinical trials are more and more complex, involving an increasing number of systems, multiple populations, and an...

Emerging Biopharma & Biotech (EBP) – 5 key success factors for your clinical trials

biotech
With so much at stake, consider partnering with an eCOA and DCT expert!Kayentis offers a unified platform featuring trustworthy services...

How is the Kayentis Clin’form solution perceived by site staff users? 

Sites perspectives
The survey, conducted in November 2022, involved 239 site respondents from Europe (47%), Americas (27%), Asia (20%), and the Middle...

Implementing electronic Patient Reported Outcomes (ePROs) in Arthritis Clinical Research: Importance, benefits, and management for incorporating ePROs

Immuno-Inflammation
Arthritis is a general term categorized by acute or chronic inflammation of the joints. Arthritis may cause a variety of...

ePRO data collection: Decision-making for the adoption of a Bring Your Own Device (BYOD) strategy

BYOD
Electronic devices have been systematically provided to participants to report Patient Reported Outcome (PRO) data in clinical trials and electronic...

Working with patient associations: What is the key to a positive interaction?

Patients insightsRare disease
What rare disease patients and families want is a simpler life. Discover here what makes the relationship between the members of...

How a patient association gave rise to a company

Patients insightsRare disease
A patient association in rare diseases is first and foremost families who all have one thing in common: they need...

Direct insights from cancer patients: How they help us understand disease burden and the need for an individualized approach

OncologyPatients insights
Cultural differences and individual preferences have a significant impact on healthcare and clinical trial experience. Solutions exist in attempt to...

Rare Disease case study

Rare disease
Over 90% of rare diseases have no treatment…  There are more than 6,000 known rare diseases... Approximately 80% of them have...

Kayentis raises further €5M to boost US activities

Additional funds will be used to scale-up Kayentis’ operations in North America to support clinical trials Grenoble, France, March 28,...

The shift to data collection at home: Strategies to support flexibility, ensure data quality, and preserve data privacy

Scientific advice
The rate at which we now collect data in clinical trials is astonishing. With decentralization of clinical trials, study data...

Insights from Kayentis clients: why you should choose Kayentis as your eCOA & DCT provider

Project management
Responsiveness, reliability, professionalism, friendliness... discover why 95.6% of Kayentis clients recommend Kayentis in 2023!Challenge your eCOA & DCT provider: choose...

2022 Employee satisfaction survey

98% of our employees are satisfied or very satisfied with their relationship with their colleagues and their management: discover the...

Clin’form App: The Kayentis BYOD solution

BYODPatient engagement
Clin’form App is the Kayentis BYOD solution, available for patients and caregivers to facilitate decentralized and hybrid trials, and improve...

Tackling the complexity of pediatric clinical trials

Pediatric
Despite the evolution in pediatric legislation and a renewed interest in developing therapeutics for pediatric and rare diseases, pediatric clinical...

Kayentis Media Player, for informed and engaged patients in clinical trials

Patient engagement
Patients taking part in clinical trials need clear and simple information – this is what 70% of 1,133 survey participants...

Let’s give a voice to trial patients with the Participant Feedback Questionnaire!

Patient engagement
The Participant Feedback Questionnaire (PFQ) is one way to engage patients by asking them about their experience of participating in...

Kayentis BYOD solution: Ensuring adoption by sites and patients

BYOD
What if a patient breaks or loses their smartphone during the study? What if they fear using the Clin’form App...

Working in collaboration with patient associations: insights from Estelle Haenel, Kayentis Medical Director

Patients insights
Whilst we hear a lot about working in collaboration with patient representatives, not so many industrial stakeholders are actually doing...

Participant Feedback Questionnaire, a voice for study patients!

Patient engagement
The need to engage patients during clinical trials is no longer debatable; the question is how clinical trial stakeholders can...

DCT and health disparities: Insights from a patient advocate

Decentralized trialsPatients insights
Basile Trimbur, Medical and Scientific Officer, Patient Engagement Lead at Kayentis, interviews Trishna Bharadia, Health Advocate & Patient Engagement Advisor,...

Big Pharma Case Study

Project management
Kayentis has more than twenty years of success stories with Big Pharma, and has been helping Big Pharma mitigate clinical...

Giving voice to study patients via the Participant Feedback Questionnaire

Patient engagement
Increasing the engagement of study patients can be done in multiple ways: one way to do it is to ask...

Televisits for more engaging clinical trials

Televisit
If it is important to enable televisits for DCT trials, embedding the feature directly into the eCOA app brings multiple...

Consider data management at each step of your study

Data management
At Kayentis, we:Make sure everyone has the same expectations for the dataThink of all the “what ifs!”Ensure the delivery of...

Decentralized Clinical Trials
Essential tips to avoid common pitfalls

Scientific advice
Despite the numerous advantages of Decentralized Clinical Trials, reducing on-site visit means that data endpoints need to be captured via...

We co-organized the France Biotech Symposium on Decentralized Clinical Trials in Paris!

Decentralized trials
Date: October 18Location: PariSanté Campus in ParisOBJECTIVES:Define decentralized clinical trials, provide an update on their development and implementation in France...

“Get ready for fully remote eCOA in your next DCT trial” webcast

Data management
Are you ready for fully remote eCOA in your next DCT trial?Learn how to build a better plan for Data...

Kayentis & RWS partnering for success

Project management
Kayentis (global provider of eCOA and DCT solutions) and RWS (language service provider (LSP) and linguistic validation experts) were selected...

Engage clinical trial participants throughout a trial
with our easy-to-use media player embedded in our eCOA app

Patient engagement
Provide clinical trial participants with clear and simple information, anywhere, anytime thanks to the Kayentis Media Player. Download the Kayentis...

“DCT is not the goal, just the means” webinar

Decentralized trials
Using technology to add flexibility to clinical trials can support patients and sites – but a thoughtful consideration of the...

Mitigating the risks of long-term oncology eCOA clinical trials

Oncology
Long study duration can have a negative impact on patient complianceAs for any clinical trial, poor compliance in oncology studies...

2021 Employee Satisfaction Survey

Discover our 2021 employee satisfaction survey results! Strong employee satisfaction and well-being at Kayentis are key ingredients for growth, enthusiasm,...

Customizing eCOA questionnaire design to improve the pediatric experience

Pediatric
Dedicated to improve patient experience in clinical trials, Kayentis’ Clin’form solution offers the flexibility to customize questionnaire design with illustrations...

Televisits in clinical trials: Why integrate a telemedecine feature in your eCOA solution?

Televisit
With clinical trials digitalization and decentralization comes the possibility for patients to complete several of their clinical study procedures remotely,...

Addressing the specific complexities of oncology eCOA clinical trials

Oncology
The oncology research pathway is paved with numerous challenges, and oncology clinical trials have one of the lowest success rates....

Decentralized Clinical Trials
Using Kayentis’ unified platform for an enhanced patient experience

Patient engagement
Improving patients’ experience using Kayentis unified platform and implementing robust technology integration.Visiting sites remotelyReceiving study information and supportProviding study experience...

Oncology Case Study

Oncology
Oncology studies present specific challenges that generate complex eCOA build and management: complex study design, frequent amendments, and long study...
Default Image

Kayentis launches fully integrated platform for decentralized clinical trials

Grenoble, France, March 23, 2022 - Kayentis, a global provider of eCOA and Decentralized Clinical Trial solutions, today announces the...

Interview mode: a valuable data collection alternative supporting Decentralized Clinical Trials

Patient engagement
Collecting ePRO & eObsRO data via interview mode can be recommended in specific circumstances, according to the medical conditions, operational...

2021 Customer Satisfaction Survey

Project management
90.8% of our clients are likely to recommend Kayentis to a colleague or a friend. Ensure the success of your...

Dermatology Case Study

Dermatology
Kayentis offers extensive expertise in dermatology and a solid experience with several typical PROs, ClinROs and Patient Diaries.With a large...

Choose a strong partner to ensure the success of your decentralized clinical trials!
6 good reasons to select Kayentis

Choose a strong partner to ensure the success of your decentralized clinical trials! Download the infographic Get your demo

DCT trials

Decentralized trials
The added value of a single platform DCT trials means bringing the study to the patient’s environment instead of asking...

Expanding flexibility of eCOA data collection with controlled interview mode

Patient engagement
With quickly evolving technologies, electronic Patient Reported Outcomes (ePROs) can now be administered in a variety of ways. If ePRO...

Patients as partners in clinical trials – Survey results

Patients insights
We collaborate with patients to characterize their clinical trials expectations and better understand their readiness for remote clinical trials.This 11-question...

Key considerations for the implementation of successful Decentralized Clinical Trials (DCTs)

Decentralized trials
Many chronic diseases such as invasive cancers, inflammatory disorders, cardiovascular, or central nervous system diseases can have a significant impact...

3 good reasons to adopt Decentralized Clinical Trials (DCT)

Decentralized trials
The clinical trials industry has been facing numerous and long-lasting challenges of patient recruitment and retention, patient compliance, and clinical...

3 Key Recommendations For A Successful BYOD Study

BYOD
BYOD is a patient-centered method of collecting patients’ data electronically during clinical trials, providing strong value for pharma organizations and...

Paving the way towards carbon neutral eCOA trials

CSR
COVID-19 caused businesses to adopt new practices, including moving many operations online and leading to a positive impact on CO2...

How to improve site experience through IRT and eCOA integration?

Interoperability
The Clin’form eCOA solution is ready for integration with any IRT system: benefit from our open eCOA platform to optimize...

Patients are ready for BYOD – are you?

BYOD
Patients are ready to adopt BYOD: 45% of patients prefer BYOD, 40% have no preference, and 15% prefer provisioned device....

Do we have the right understanding of how patients perceive digital clinical trials?

Patients insights
Interview with Trishna Bharadia, Health Advocate & Patient Engagement Advisor on the 1,133 patients survey results conducted by Kayentis in...

Clinical trials digitalization: why it helps clinical trials stakeholders

The decline in R&D efficiency is one of the biggest challenges the pharmaceutical industry is facing today. The development of...
Default Image

How can digital innovation turn clinical trials into a positive patient and site experience?

Digital innovation is increasingly penetrating the healthcare industry and technological advances create a new avenue for the optimization of clinical...

Data Management – Essential for all studies including eCOA

Data management
  In a perfect world, you would choose your Clinical Outcome Assessments (COAs), write your statistical analysis plan (SAP), license...

BYOD: When, why and how?

BYOD
What are the main characteristics that make BYOD a strong feature for decentralized trials? What are the key factors to...

WebCOA back-up
The best balance for data quality, ease-of-use, and cost for your clinical studies!

webcoa
7 reasons to choose a web-based back-up solution for your eCOA studies   WebCOA is a back-up solution, which is...

Digitalization Trends in Tackling the Complexity of Clinical Trials for Patients with Multiple Health Conditions

Rare disease
Patients participating in clinical research face a whole range of challenges, and it is particularly worse for those living with...

Do we really know what clinical trial patients need?

Patients insights
Let’s challenge our beliefs: Do we really know what clinical trial patients need? Do we have the right understanding of...

2020 Employee Satisfaction Survey

CSR
Embrace our spirit! With a 19% increase in new employees in 2019, the Kayentis team spirit is still going strong!...
Default Image

Let’s listen to what patients have to tell us!

Patients insights
Because of the pandemic, have you felt... …anxious for your/your family’s health? …worried for your job? …isolated or lonely during...

eCOA setup: How to ensure a successful launch by navigating complexities

Project management
Discover the presentation on eCOA setup held by Estelle Haenel, Medical Director @Kayentis, during Clinical Trials Europe and Outsourcing in...

2020 Customer Satisfaction Survey

Project management
88.1% of our customers are likely to recommend Kayentis to a colleague or friend!Thank you to all our customers! We...

Plan a successful web back-up strategy for your clinical trials

webcoa
Have you anticipated all situations? Discover the key advantages of our WebCOA back-up! Guarantee patient & site compliance Site staff...

eCOA solutions in oncology: how to avoid common pitfalls and ensure the success of long-term studies?

Oncology
Among numerous clinical study procedures, capturing patients reported outcomes can bring its own set of challenges and, if not well...

Partnering with patients to boost clinical research in rare diseases

Patients insightsRare disease
Although much progress has been made in developing scientific knowledge and conducting clinical research in rare diseases, serious challenges remain....

eCOA back-up strategies

No longer the “what if” situation: today’s reality and eCOA back-up strategies.How to ensure they are adapted? There have always...
Default Image

Press Release // Kayentis raises €7M ($8.3M) to accelerate the global expansion of its digital platform for clinical trials

Funds will strengthen Kayentis’ digitalization approach in transforming how pharma, investigator sites and patients engage in clinical trials Grenoble, France,...

eCOA set-up

Project management
How to anticipate eCOA complexities and ensure a successful launch? Setting up a study with eCOA should be straight forward:...

eCOA challenges of long term studies

OncologyProject management
How to anticipate eCOA complexities in multi-year studies & develop best practice to support sites? Using eCOA solutions can bring...

Kayentis Program for Carbon-Neutral Clinical Trials

CSR
"Through the quality of the solutions, services, and databases that we provide to sponsors and CROs, we contribute to the...

Press Release // Kayentis launches new initiatives to bolster carbon-neutral clinical trials

CSR
Carbon-neutral program takes aim at reducing CO2 emissions in clinical trials, particularly phase III, without impacting their cost, quality or...

Make it simple: Use a single device! #infography

Discover the 3 key advantages of using a single device for both on-site and home use: #1 Simplicity for sites#2...

REGISTER FOR OUR VIRTUAL PRESENTATION – Nov 3, Clinical Trials Europe

eCOA SETUP: HOW TO ENSURE A SUCCESSFUL LAUNCH BY NAVIGATING COMPLEXITIES Prepare Specifications: how to mitigate risk and anticipate complexities...

eCOA Training: how can we improve the sites’ and patients’ experience? #whitepaper

Patient engagementProject management
Focused on eCOA training, this white paper transcribes the discussion from one in a series of 4 workshops about eCOA...

Make clinical trials an enjoyable experience: use a small tablet device! #infography

A small tablet is the perfect choice between a smartphone and a "classic" tablet. A user-friendly device, it is adapted...

2019 Employee Satisfaction Survey

CSR
Embrace our spirit! With a 19% increase in new employees in 2019, the Kayentis team spirit is still going strong!...

eCOA in ophthalmology: The five keys for successful ePRO selection in your ophthalmology clinical trial

Ophthalmology
There is an extended use of Patient Reported Outcome (PRO) measures in clinical trials used to assess health-related quality of...

eCOA in ophthalmology

Ophthalmology
There is an extended use of Patient Reported Outcome (PRO) measures in clinical trials used to assess health-related quality of...

Put an end to eCOA misconceptions #infography

Discover below the 5 reasons to adopt eCOA solutions.Want to learn more about eCOA misconceptions? Click here! To download "Put...

eCOA training: How to maximize data collection and completeness?

Data managementProject management
Although tablets and smartphones are widely used nowadays, not everybody is yet familiar with these devices. An adapted training will...

Infography: Overcoming complexities in pediatric clinical studies

Pediatric
Approximately one in every five pediatric clinical study fail1,2 . A 2016 study shows that over a three-year period (2008 -2011),...

Key #5 for successful ePRO selection in your ophthalmology clinical trial: Anticipate cultural differences in multi country clinical trials

Ophthalmology
https://youtu.be/-dWvQaRUwYs Before selecting a PRO for use in a large global trial, it is important to anticipate that responses to...

Kayentis supports the 1st personalized immunotherapy treatment approved by both FDA & EMA

Oncology
Acute Lymphoblastic or Lymphoid Leukemia (ALL) is a cancer of the lymphocytes that can result in serious complications such as...

ePRO and eDiary: What about using a single device?

With the increasing importance of direct patient input into clinical trials, most protocols combine ePRO and eDiary questionnaires for use...

Patient Reported Outcomes: don’t skip that question!

When setting up Patient Reported Outcomes (PRO) for Clinical Trials, at some point you will inevitably consider the option of...

Press Release // Kayentis forges ahead on five new eCOA service projects with emerging biopharma firms in Europe and US

Kayentis sets up incoming EBPs, major contributors in biomedical innovation, as well as its existing clients, with contingency plans to...

3 reasons for using tablet for clinical data collection @Home

Electronic capture of patient data is increasingly replacing the use of paper-based diaries, and electronic Clinical Outcomes Assessment (eCOA) tools...

Technological ways to make clinical trials really global

Although clinical trials are meant to cover global populations, the pool of patients currently enrolled in clinical trials is not...

Overcoming the Complexities of Pediatric Clinical Trials

Pediatric
Although children make up 25% of the world’s population, at least 50% of all drug products may still lack labeling...

Key #4 for successful ePRO selection in your ophthalmology clinical trial: Consider the method of ePRO administration

Ophthalmology
https://youtu.be/cY5lYM_wBDQ PROs in ophthalmology trials can either be self-administered by the patient or the responses can be collected through an...

Key #3 for successful ePRO selection in your ophthalmology clinical trial: Get your patients involved

Ophthalmology
https://youtu.be/Cp7vd1fBKbc Although clinical research stakeholders strive to be patient-centered in their approach, dependence on clinical parameters alone is not enough....

Key #2 for successful ePRO selection in your ophthalmology clinical trial: Use your PROs to power economic evaluations

Ophthalmology
https://youtu.be/rH4yG-sxE9w Incorporating an economic evaluation within a trial provides valuable information for clinical decision making and coverage determinations, particularly when...

Misconception #5 on eCOA barriers: Regulatory bodies are reluctant to accept eCOA data

https://youtu.be/C1bRj8NwM7Y There seems to be a lot of uncertainty here as people tend to think that electronic data acceptance by...

Misconception #4 on eCOA barriers: Preparing for eCOA requires additional lead time

https://youtu.be/gmnVSwOoIiI Time is of the essence for any clinical study. Nobody wants to lose time when starting a clinical trial....

Key #1 for successful ePRO selection in your ophthalmology clinical trial: Ensure the ePRO answers the intended clinical endpoint

Ophthalmology
https://www.youtube.com/watch?v=eHQWWje4VwI&feature=youtu.be PROs have become a vital part of modern ophthalmology with an increasing focus on PROs within high-quality ophthalmic trials....

Misconception #3 on eCOA barriers: eCOA implementation requires higher investment

https://youtu.be/G_bGrZ6nXbk A general misconception is that eCOA implementation will generate additional costs. Early investment is required for eCOA implementation that...

Misconception #2 on eCOA barriers: Data might be lost due to device failure

https://youtu.be/vCsK9JI61-U The fear of losing data is more than legitimate. As clinical trial stakeholders you will have good stories to tell...

Misconception #1 on eCOA barriers: Patient training and re-training plan is a burden

https://youtu.be/y22gyfmBYsU As “end users “of innovative technologies, site staff and patients need to embrace the digital transformation as much as...

Are barriers to eCOA adoption true hurdles?

Over recent years, as an industry, we seem to have created a paradox: we increase investment in technological developments, but...

eCOA Back-up Solutions: Perception vs Reality

Digital solutions have without a doubt improved both the quality and the quantity of data collected in clinical trials. The...

Press Release // Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector

Proximity will facilitate local and international sponsor access to Kayentis’ eCOA services for mid- to later-stage clinical trials Kayentis will...

Kayentis gives back to its community by donating to two local associations

CSR
Aware of its responsibility towards the environment, Kayentis decided to help financially two health-focused associations in Grenoble and Meylan.  The...

Kayentis extends its contribution to scientific research in clinical trial endpoint assessment and joins the Critical Path Institute’s ePRO Consortium

eCOA consortium
Kayentis announces that it has joined the C-Path's ePRO Consortium, a nonprofit organization dedicated to advance the science of clinical...

eCOA study: Paper back-up and data reliability

Data management
eCOA study: the impact of a paper back-up system on data reliability In any eCOA study, a data back-up solution...
Default Image

Press Release // Kayentis appoints Estelle Haenel as medical director

Scientific advice
25-year pharma industry veteran and clinical trials expert will strengthen Kayentis’ eCOA offering to sponsors seeking to use digital patient-facing...

Inclusion and gender diversity is not a given!

CSR
This can only be the result of a balanced and robust Human Resources policy.             ...

2018 Employee Satisfaction Survey

CSR
The results are in! 2018 was marked by an increase of 35% in new employees at Kayentis. We are committed...

The benefits & practicalities of aligning the objectives of an eCOA vendor with those of the study

Project management
Any enduring business relationship between a service provider and a client is built on a thorough understanding of the client’s...

Including eCOA in a clinical trial in China

With a large patient pool and growing pharma market opportunities, study sites in China are included in more and more...

Six reasons to work at Kayentis

CSR
Here are 6 reasons to knock at our door! At Kayentis, a global eCOA provider, the quality of life at...

Kayentis welcomes Estelle Haenel, PharmD, PhD, as Medical Director

Scientific advice
Estelle Haenel has joined Kayentis as Medical Director. She will help leverage the company’s growing medical expertise bringing to Kayentis...

Waste Management Report 2018

CSR
Kayentis is committed to responsible waste management After the promotion of environmentally friendly transport - 2018 Sustainable Mobility Report - (e.g....

Implementing Kayentis Spirit in the US, a key challenge for Kayentis team

Interview with Björn Felber – Project Director, Kayentis US In June 2018, Kayentis was strengthening its presence in the US...

Challenges of back-up solutions in eCOA studies

Why is there a need for a back-up solution? In some cases, the eCOA user (investigator/site staff, patient, or observer)...

Sustainable Mobility Report 2018

CSR
Moving together towards a better tomorrow At Kayentis, we recognize that we all play a part in ensuring each other’s...

Press release // OMRON Healthcare and Kayentis join forces to deliver an integrated and cost-efficient approach to remote monitoring of patients in clinical trials

We are proud to announce our collaborative work with OMRON Healthcare on the development of an integrated and cost-efficient approach...

Kayentis releases its 2018 customer satisfaction survey: The results are in!

Project management
Customer satisfaction survey 2018: The results are in! Rapid growth and diversification of clients brought new challenges this year, so...

Support from Bpifrance & Europe

We are proud to announce that Kayentis has received support from Bpifrance & Europe for the development and industrialization of...

Consolidation in the eCOA industry: How does this impact the quality of service delivery? and the choice of service providers?

The eCOA industry continues to evolve with yet more consolidation amongst traditional providers. Given the longitudinal nature of many eCOA...

Kayentis, a global expert in eCOA, is strenghening its US presence

Kayentis, expert in eCOA, is stengthening its presence in the US and opening offices in Boston. Guillaume Juge, Kayentis CEO...

Infography: Employee Satisfaction Barometer 2017

CSR
Well-being at Kayentis is rated 8/10! We are proud to publish the good results of our 2017 employee satisfaction barometer:...

Kayentis announces the release of its new eCOA solution, Clin’form3 Suite

A multi-platform eCOA solution to address the clinical trial needs of the future Over the last 2 years, Kayentis has...

Infography: Kayentis added values for CROs

Kayentis is a global eCOA vendor created in 2003, 100% dedicated to eCOA. Here is an overall infography about Kayentis...

Mobile technologies & wearable devices for Healthcare and Clinical Research

Mobile technology & wearable devices are becoming increasingly prominent in healthcare and clinical research, but we're only starting to understand...

// White paper // Digital Technology and Patients Tools in Clinical Trials – Part 2

Moving on from the “Selection & Evaluation of Technology Service Providers White Paper Part 1”, this white paper about digital...

Joining Kayentis: Values, mission and vision

Joining Kayentis means also joining a company with its own values, a real vision and a concrete mission. Beyond being...

// White paper // Digital Technology and Patients Tools in Clinical Trials – Part 1

Digital technology today has become an important tool in facilitating access to and engagement with the subjects participating in clinical...

// White paper // The European Union General Data Protection Regulations

The European Union (EU) Data Protection Regulations (GPDR), effective from 27 April 2016, will apply to all organisations responsible for data...

// Innovation by Kayentis // R&D moves into an ‘Agile’ mode of operation

How the Agile mode, implemented in Kayentis’ R&D department, improves the quality of solutions as well as client satisfaction. It’s...

What can eDiary bring to your study?

During a clinical trial, in particular for late phase trials, it becomes increasingly important to be able to collect a...

Accreditation by the French Ministry of Research

‘We are proud to announce that we have been accredited by the French Ministry of Research as an organisation that...

Infography: 7 lesser known advantages of eCOA over COA

Advantages of eCOA: Clinical Outcomes Assessment (COA) data in clinical and epidemiological studies can be collected using traditional paper questionnaires...

// White paper // Local storage or Cloud hosting?

Over the last 25 years the collection of clinical research data has moved from paper-based systems to electronic data capture...

Actigraphy devices: a real impact on clinical research?

Actigraphy has been used in clinical trials for almost 20 years. Recently their inclusion in study protocols has been increasing,...

Advantages of direct review of patient-recorded data by clinicians

In ePRO clinical trials, patients may use tablets to record their data. What if the clinician uses the same device...

//White paper// eCOA vs COA: pros and cons

Electronic tools allow the collection of data (electronic Clinical Outcomes Assessments [eCOA]) from patients, physicians, observers (mainly parents), and caregivers...

Hidden costs of paper ICFs

The past few years have seen a new breakthrough in electronic data capture: the electronic Informed Consent Form (eICF). Nowadays,...

Infography: planning an oncology study with eCOA/ePRO

The FDA has provided guidance on methodology to be used for developing and using PRO in oncology drug development programmes,...

Data Management: a key factor in data quality

Data management
The constant increase in the volume of clinical data and the emergence of new technologies in the medical field over...

Kayentis announces a breakthrough feature available in ePRO clinical trials: clinician review of data on a tablet device

It is essential that clinicians review PRO data. When patients complete questionnaires using a tablet, the use of different device...

eCOA solutions in oncology: What to consider when planning an oncology study with eCOA /ePRO?

The FDA has provided guidance on methodology to be used for developing and using PRO in oncology drug development programmes,...

//COAs white paper// Why are they important criteria in the evaluation of dossiers by health authorities?

Diverse elements have combined in recent years to make Clinical Outcome Assessments (COAs), and particularly Patient Reported Outcomes (PROs), important...
Default Image

Kayentis goes one step further in the integration of electronic Informed Consent to improve patient convenience and sponsor efficiency

The announcement in May 2016 of the partnership between Kayentis and SecureConsent was just the first step in the integration...

Kayentis releases its 2016 customer satisfaction survey

Project management
Kayentis proud to publish the results of its customer satisfaction survey Conducted among more than 60 Kayentis clients, this investigation reveals that 90% of surveyed...

Kayentis closes 3.6 M€ growth financing round

Innovation Capital and Extens finance 3.6 M€ round to accelerate the international growth of Kayentis. Kayentis, a global provider of electronic...

KAYENTIS announces its participation in the Avoca Diligent Prequalification Platform

Choosing a provider in the clinical trials market is a costly and time-consuming process for sponsors and CROs. To better...

How to handle connectivity issues in electronic Clinical Outcome Assessment (COA) clinical studies?

Connectivity is key when using electronic Clinical Outcome Assessment (eCOA) tools in clinical studies. But what are the requirements of...

Key benefits of using a “Tablet device” for eCOA in Psoriasis studies

Psoriasis is a chronic immune-mediated inflammatory disease of the skin with various presentations and clinical courses. The commonly used measures...

How to choose an electronic Clinical Outcome Assessment (eCOA) backup solution?

In recent years the use of electronic Clinical Outcome Assessment (eCOA) tools to improve clinical data quality has become more...

The benefits of the eICF in patient engagement

The patient’s role in clinical trials, as well as the general image of patient care, is evolving. The patient is...

The 6 challenges to succeed in a global eCOA study

Several elements have to be respected in order to succeed in achieving a global eCOA study. Here is a list...

Infography to find out how to switch from COA to eCOA

Infography COA to eCOA: in many cases this move from COA to eCOA generates cost cuts for the sponsor as...

Switching from COA to eCOA – 6 points checklist

Benefits generated by a switch from COA to eCOA have already been clearly demonstrated by many: it allows instant access...

How complex authentication should be in eCOA devices?

Authentication is a requirement that can’t be underestimated. It is key that user’s identity is guaranteed, but daily usage should...

A step further in improving clinical trials: an electronic informed consent fully integrated into the eCOA solution

KAYENTIS signs a partnership with eNFORME to combine SecureConsent® eICF solution with Kayentis eCOA’s platform. From now on, Kayentis provides...

Kayentis signs up 5 new phase III clinical studies

These phase III clinical studies, supported by Top10 pharma laboratories, will be using the tablet-based data capture solution developed by...

Kayentis announces the creation of its strategic committee

Four leading figures in Life Sciences have accepted director Guillaume Juge’s invitation to join the body and they are Pr...

Kayentis finalized its round of funding in february

Kayentis finalized in February 2015 a round of funding with the arrival of Extens, a fund dedicated to e-health, alongside...
Follow us on social media
Subscribe to our newsletter
You may also like

Kayentis and RWS join forces to improve data confidence in...

What if eCOA could elevate your next rare disease trial?

Elevating rare disease clinical trials through eCOA – From patient...

Overcoming rare disease trial challenges: the strategic impact of eCOA

Kayentis and Perceptive eClinical partner to tackle increasing digital system...

Raising the bar again: Kayentis achieves 95.9% client Recommendation Rate...

About the author
Picture of Céline Hollinger

Céline Hollinger

Celine brings almost two decades of communications experience in the life sciences. As a co-founder of a healthcare communication agency for over a decade, she has supported top pharma and innovative healthcare companies. Since April 2019, she has been leading marketing and communication at Kayentis with her innovative strategies.
Kayentis and RWS join forces to improve data confidence in neuroscience clinical trials
Combining best-in-class eCOA technology with expert rater training to reduce variability and strengthen clinical outcomes data in CNS and other complex disorder clinical trials.
  • Read the full press release